Cargando…
Dimeric Benzodiazepines as Peptide Mimetics to Overcome p53-Dependent Drug Resistance of Tumors
Benzodiazepines that consist of one α- and one β-amino acid residues linked together in a seven-membered heterocyclic ring could be treated as small, rigid, cyclic dipeptides capable of exhibiting a wide range of biological activities. During our research on novel analogues of anthramycin, a tricycl...
Autores principales: | Speina, Elżbieta, Wilczek, Marcin, Mieczkowski, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953746/ https://www.ncbi.nlm.nih.gov/pubmed/36830660 http://dx.doi.org/10.3390/biom13020291 |
Ejemplares similares
-
Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis
por: Pujals, A, et al.
Publicado: (2011) -
Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery
por: Bian, Zhenyuan, et al.
Publicado: (2018) -
Collagen Mimetic Peptides
por: Xu, Yujia, et al.
Publicado: (2021) -
Overcoming EMT-driven therapeutic resistance by BH3 mimetics
por: Keitel, Ulrike, et al.
Publicado: (2014) -
Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs
por: García, Miguel Angel Fernández, et al.
Publicado: (2018)